A possible link between resveratrol and TGF-beta: resveratrol induction of TGF-beta expression and signaling (Q40017808)

16 September 2017

title

A possible link between resveratrol and TGF-beta: resveratrol induction of TGF-beta expression and signaling (English)

1 reference

16 September 2017

Fumiko Suenaga

1

1 reference

16 September 2017

Kyosuke Hatsushika

2

1 reference

16 September 2017

Shinichi Takano

3

1 reference

16 September 2017

Takashi Ando

4

1 reference

16 September 2017

Yuko Ohnuma

5

1 reference

16 September 2017

Hideoki Ogawa

6

1 reference

16 September 2017

Atsuhito Nakao

7

1 reference

16 September 2017

language of work or name

English

0 references

publication date

31 January 2008

1 reference

16 September 2017

1 reference

16 September 2017

volume

582

1 reference

16 September 2017

issue

5

1 reference

16 September 2017

page(s)

586-590

1 reference

The health benefits of wine

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.024

Biological effects of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.024

Cancer chemopreventive activity of resveratrol, a natural product derived from grapes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.024

Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.024

Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.024

Role of transforming growth factor beta in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.024

Making sense of latent TGFbeta activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.024

TGF-beta signalling from cell membrane to nucleus through SMAD proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.024

Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.024

Suppression of atherogenesis by delivery of TGFbeta1ACT using adeno-associated virus type 2 in LDLR knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.024

TGF-beta signaling in tumor suppression and cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.024

Successful shape-based virtual screening: the discovery of a potent inhibitor of the type I TGFbeta receptor kinase (TbetaRI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.024

A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.024

Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.024

Transforming growth factor-beta(2) polymorphisms are associated with childhood atopic asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.024

10.1016/J.FEBSLET.2008.01.024

21 January 2018

Identifiers

DOI

1 reference

16 September 2017

1 reference